Elevated endothelial microparticles in fabry children decreased after enzyme replacement therapy [3]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 7, 2007, Pages

  Gelderman, Monique P ^a   Schiffmann, Raphael ^b   Simak, Jan ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGALSIDASE ALFA; ENDOGLIN; VASCULAR ENDOTHELIAL CADHERIN;

ADOLESCENT; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG EFFECT; ENDOTHELIUM; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; HUMAN; LETTER; MALE; OUTCOME ASSESSMENT; PARTICLE SIZE; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS; TREATMENT DURATION;

ADOLESCENT; ALPHA-GALACTOSIDASE; ANTIGENS, CD; BIOLOGICAL MARKERS; CADHERINS; CASE-CONTROL STUDIES; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; FABRY DISEASE; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; ISOENZYMES; MALE; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 34250809070     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.143511     Document Type: Letter

References (6)

1. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med. 1967;276:1163-1167.
2. Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M et al. Agalsidase-beta therapy for advanced Fabry disease. Ann Intern Med. 2007;146:77-86.
3. Schiffmann R, Kopp JB, Austin III HA, Sabnis S, Moore DF, Weibel T et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. J Am Med Assoc. 2001;285:2743-2749.
4. Ries M, Clarke JTR, Whybra C, Timmons M, Robinson C, Schlagger BL, Pastores G, Lien YH, Kampmann C, Brady RO, Beck M, Schiffmann R. Enzyme-replacement with agalsidase alfa in children with Fabry disease. Pediatrics. 2006;118:924-932.
5. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: Potentially pathogenic agents and diagnostic markers. Transfusion Med Rev. 2006;20:1-26.
6. Simak J, Gelderman MP, Hua Y, Wright V, Baird AE. Circulating endothelial microparticles in acute stroke: A link to severity, lesion volume and outcome. J Thromb Haemost. 2006;4:1296-1302.